Johnson & Johnson's nipocalimab has been granted U.S. Food and Drug Administration Fast Track designation as a potential treatment for adults with systemic lupus erythematosus (SLE). Fast Track ...
The FDA Modernization Act of 1997 established the Fast Track designation to expedite developing and reviewing new drugs designed to fill unmet medical needs and treat serious conditions. The FDA Fast ...
The State Department is launching a pilot for B1/B2 applicants. Learn how to apply, how the 10-day timeline works, and the risks.
GREEN BAY, Wis.--(BUSINESS WIRE)--Schneider National, Inc. (NYSE: SNDR), a premier multimodal provider of transportation, intermodal and logistics services, is introducing Schneider Fast Track, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results